Zydus Lifesciences Moves Forward with Amplitude Surgical Acquisition

On April 17, 2025, Amplitude Surgical announced that Zydus Lifesciences Limited is advancing in its process to acquire Amplitude Surgical SA shares. Seven shareholders have committed to tender 2,236,911 shares, representing 4.7% of the company’s capital and voting rights. This follows the announcement of a potential tender offer made on March 11, 2025.

Zydus Lifesciences plans to acquire 85.6% of Amplitude Surgical's capital from PAI Partners, management, and minor shareholders. Combined with the new commitments, Zydus will hold more than 90% of the capital and voting rights, pending no competing offers. Completion of the acquisition is anticipated by June 2025, subject to regulatory approvals.

The tender offer awaits clearance from the Autorité des marchés financiers. An update on the proceedings is expected imminently. Amplitude Surgical's next release will discuss its 9-month sales results for 2024-25.